Tamiflu (Oseltamivir Phosphate) Market, by Drug Type (Branded and Generic), by Dosage Form (Capsules and Suspension), by Indication (Influenza A, Influenza B, and Swine Flu (H1N1 Influenza A)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
Oseltamivir phosphate is indicated for the treatment of influenza A, influenza B, and Others. It reduces the symptoms caused by influenza virus such as stuffy nose, cough, sore throat, fever/chills, aches, and tiredness. Moreover, the medicine reduces the recovery time by 1-2 days. This medication may also be used to prevent the flu if the person is exposed to other patient who already is suffering from flu or if there is a flu pandemic in the community. The mode of action for the treatment is that, this medication works by stopping the flu virus from growing. The medicine should be taken at the proper time interval as prescribed by the doctor. If the intake of medicine is terminated at an early stage then, this may lead to the growth of the virus, which may relapse of the infection.
Market Dynamics
Increasing incidence of influenza among the U.S. population is expected to increase the growth of the global Tamiflu (oseltamivir phosphate) market over the forecast period. For instance, according to the article published in the Lancet journal, 2022, the annual incidence of symptomatic influenza is estimated to vary from 3 to 11%. According to the various studies carried out by the researchers in National Center for Immunization and Respiratory Diseases, U.S., it was found that, influenza virus infections and illness rates are highest in children and the rate of illness decrease with the increasing age.
Increasing launches of Tamiflu (oseltamivir phosphate) is expected to drive the growth of the global Tamiflu (oseltamivir phosphate) over the forecast period. For instance, in 2018, Natco Pharma, Indian pharmaceutical company and their marketing partner Alvogen, U.S. based pharmaceutical company launched, the first generic version of Tamiflu (oseltamivir phosphate) in the U.S.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook